Biocon

Dr Rakesh Bhasin, Head R&D (Formulations), Biocon, gave a presentation on 'The R&D playbook for complex generics'. He…

Biocon, an innovation-led global biopharmaceutical company has announced the inauguration of its first US manufacturing facility…

The eighth edition of the FDD Conclave organised by Express Pharma witnessed a very interesting panel discussion on Injectable…

ATMF report recommends practical solutions whereby companies can bring about the fundamental shift that is required to scale up…

Settlement agreement allows Biocon Biologics to commercialise interchangeable aflibercept biosimilar Yesafili in the US; launch…

Biocon’s subsidiary Biocon Biologics, which also participated independently in the assessment for the first time, reported an…

Industry experts highlight the progress made by the Indian biopharma sector, and suggest pathways to promote growth

This is based on a surveillance inspection conducted by the USFDA between September 23-27, 2024

Event to focus on innovation, sustainability, and India’s growing role in the global pharma sector

This year’s ranking is based on a comprehensive web-based survey of about 6,400 respondents